Study Stopped
All clinicial studies were stopped during the Covid-19 pandemic. Interventions not possible to perform, neither at workplace nor at the gym.
Return to Work in Patients With Chronic Pain
UWORKin
Vocational Rehabilitation and Return to Work in Patients With Chronic Pain: a Randomised Controlled Trial
1 other identifier
interventional
8
1 country
1
Brief Summary
This study aims to evaluate whether a vocational behaviour change ability programme has any additional effect on return to work compared with return to work coordination only in persons with chronic pain.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable chronic-pain
Started Aug 2019
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
January 24, 2019
CompletedFirst Posted
Study publicly available on registry
February 1, 2019
CompletedStudy Start
First participant enrolled
August 14, 2019
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
February 1, 2021
CompletedSeptember 28, 2023
September 1, 2023
8 months
January 24, 2019
September 25, 2023
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
Return to work
Average sick leave according to the Swedish Social Insurance registry, defined as net days.
Number of days during a 12-month period from baseline to 12 months post baseline.
Work ability
Self-report. Work Ability Index (WAI). The questionnaire covers 7 dimensions: 1. current work ability compared with lifetime best 2. work ability in relation to the demands of the job 3. number of diagnosed illnesses or limiting conditions 4. estimated impairment owing to diseases/illnesses or limiting conditions 5. amount of sick leave during the last year 6. prognosis of work ability in 2 years' time 7. psychological resources. The dimensions have different scores. A total index is computed ranging from 7 to 49, where higher scores indicate higher work ability.
12 months
Secondary Outcomes (22)
Work Ability
Baseline, 6 months, 24 months
Return to work
Baseline, 6 months, 24 months
Short-term sick leave < 2 weeks, number of days
6 months, 12 months, 24 months
Health-related quality of life: EQ-5D
Baseline, 6 months, 12 months, 24 months
Opioid use
Baseline, 6 months, 12 months, 24 months
- +17 more secondary outcomes
Other Outcomes (3)
Patient-specific goals for return to work
Baseline, 6 months, 12 months
Self-efficacy to support return to work (employer): Number of items
Baseline, 6 months
Number of participants who report adverse events associated with treatment
Up to 6 months
Study Arms (2)
Comparison intervention
ACTIVE COMPARATORReturn To Work Coordination: external and internal coordination regarding sick leave. Establishment of a common return to work plan between employer and employee.
Experimental intervention
EXPERIMENTALReturn To Work Coordination + Behaviour Change Ability Programme Behaviour Change Ability Programme: 1. Return to work coordination 2. Education for employers and employees in pain neuroscience, validation, and problem-solving 3. Patient specific goal setting for return to work 4. Exercise and behavioural skills training related to return to work
Interventions
External and internal coordination regarding sick leave. Establishment of a common return to work plan between employer och employee.
1. Return to work coordination 2. Education for employers and employees in pain neuroscience, validation and problem-solving. 3. Patient-specific goal setting for return to work 4. Exercise and behavioural skills training related to return to work
Eligibility Criteria
You may qualify if:
- Chronic pain with a duration for more than 3 months
- On sick-leave 25%-100% from salaried employment or studies, for at least 30 days
- Identified employer or director of studies
- Ability to understand, speak, and write Swedish
You may not qualify if:
- Severe substance use disorder
- Severe psychiatric illness
- Recruited participants with employers who does not consent to participate
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Uppsala Universitylead
- Uppsala University Hospitalcollaborator
- AFA Insurancecollaborator
- The Swedish Research Councilcollaborator
- Uppsala County Council, Swedencollaborator
Study Sites (1)
Uppsala University Hospital
Uppsala, Uppland, 75226, Sweden
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Pernilla Åsenlöf, Professor
Department of Neuroscience, Uppsala University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- TRIPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, OUTCOMES ASSESSOR
- Masking Details
- The outcomes assessors are blinded to study condition during all measurements. Participants and providers of the return to work coordination intervention are blinded until a rehabilitation plan has been completed. Thereafter allocation to study condition is disclosed and the other components of the behaviour change ability programme are provided to those in the experimental group.
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Professor
Study Record Dates
First Submitted
January 24, 2019
First Posted
February 1, 2019
Study Start
August 14, 2019
Primary Completion
April 1, 2020
Study Completion
February 1, 2021
Last Updated
September 28, 2023
Record last verified: 2023-09